Tradestie Institutional Equity Comparison Engine

CERS vs COCH โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CERS Overall Edge

CERS Captures Institutional Edge (2โ€“2 Pillars ยท 5โ€“4 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Cerus Corp (CERS) driven by superior Valuation, Options & Structure while COCH counters with relative strength in Growth & Margin, Momentum & Technical. Fundamentally, CERS trades at 123.3x Forward P/E with -1.1% operating margin (+9.5% YoY revenue) versus COCH at N/M Forward P/E and -10261.0% operating margin (+57.1% YoY). In options structure, CERS sits in BREAKDOWN (32nd %ile IV; Dealer Gamma Walls on Pro) against COCH sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CERS
CERS 123.3x vs COCH N/M Fwd P/E
Growth & Margin Winner COCH
Op Margin -1.1% vs -10261.0% ยท YoY +9.5% vs +57.1%
Momentum & Technical Winner COCH
1Y +22.5% vs +843.4% ยท 52W Pos 19% vs 89%
Options & Structure Winner CERS
BREAKDOWN (32nd %ile IV) vs UNCLASSIFIED (N/A IV)
CERS NASDAQ
Cerus Corp
Surgical & Medical Instruments & Apparatus
$1.85
-2.63% 1D
Market Cap $383.7M
1M Return -19.91%
1Y Return +22.52%
Forward P/E 123.3x
Unified AI Score
55.5 / 100 HOLD
Tech 60.0 Fund 64.0 Flow 66.0 Mom 60.0
COCH NASDAQ
Envoy Medical, Inc. Class A Common Stock
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$6.70
+0.0% 1D
Market Cap $51.9M
1M Return +1024.35%
1Y Return +843.4%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 50.0 Fund 27.0 Flow 50.0 Mom 40.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CERS +22.52% COCH +843.4% Spread: +820.88 pp (COCH Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period CERS Revenue COCH Revenue CERS Op. Margin COCH Op. Margin Margin Edge
FY2018 $80M N/A -72.3% N/A CERS
FY2019 $90M N/A -70.6% N/A CERS
FY2020 $110M N/A -51.1% N/A CERS
FY2021 $160M N/A -30.7% N/A CERS
FY2022 $190M $0M -18.1% -3673.4% CERS
FY2023 $190M $0M -16.1% -5809.8% CERS
FY2024 $200M $0M -7.1% -8558.2% CERS
FY2025 $230M $0M -3.7% -9240.7% CERS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CERS (5) vs COCH (4)
Institutional Metric CERS COCH Criterion Row Winner
Market Capitalization Scale $383.7M $51.9M Larger Scale CERS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation 123.3x N/M Lower Multiple CERS
Revenue Growth (YoY) Growth +9.5% +57.1% Higher Growth COCH
Operating Margin (TTM) Profitability -1.1% -10261.0% Higher Margin CERS
Net Profit Margin Profitability -3.2% 0.0% Higher Margin COCH
Return on Equity (ROE) Capital Efficiency -10.7% 0.0% Higher ROE COCH
52-Week Range Position Momentum 19% ($1โ€“$3) 89% ($0โ€“$7) Stronger Trend COCH
Beta / 30D Volatility Risk Regime 1.51ฮฒ ยท 76% Vol 4.94ฮฒ ยท 3352% Vol Lower Realized Risk CERS
Unified Institutional Score Composite Signal 55.5 / 100 (HOLD) 35.1 / 100 (SELL) Higher Composite CERS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CERS vs COCH Buy Guide
CERS BREAKDOWN
122d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 32nd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live CERS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
COCH UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live COCH Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CERS nor COCH registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.